Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115784) titled 'The effect of esketamine hydrochloride on intraoperative intestinal peristalsis and postoperative gastrointestinal function recovery in patients with ERCP: A single-center, prospective, randomized, double-blind, controlled study' on Dec. 31, 2025.
Study Type: Interventional study
Study Design:
Case-Control study
Primary Sponsor: General Hospital of Ningxia Medical University
Condition:
Pancreaticobiliary diseases
Intervention:
Experimental Group:Esketamine hydrochloride at a dose of 0.3 mg/kg was administered before the operation
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: ...